C26:0-LPC has been used as a biomarker in NBS for X-ALD based on its high-levels of accumulation in patients possessing a pathogenic variant in ABCD1 and the associated defect in ALDP activity [19,20,21,22]. The gene discussed is ABCD1; the disease is X-linked adrenoleukodystrophy.